Encapsulated fusion protein confers "sense and respond" activity to chitosan-alginate capsules to manipulate bacterial quorum sensing.

Printer-friendly versionPrinter-friendly versionPDF versionPDF version
TitleEncapsulated fusion protein confers "sense and respond" activity to chitosan-alginate capsules to manipulate bacterial quorum sensing.
Publication TypeJournal Article
Year of Publication2013
AuthorsGupta, A, Terrell, JL, Fernandes, R, Dowling, MB, Payne, GF, Raghavan, SR, Bentley, WE
JournalBiotechnol Bioeng
Volume110
Issue2
Pagination552-62
Date Published2013 Feb
ISSN1097-0290
KeywordsAlginates, Animals, Antibodies, Bioengineering, Cattle, Chitosan, Escherichia coli, Glucuronic Acid, Green Fluorescent Proteins, Hexuronic Acids, Homoserine, Lactones, Nanocapsules, Nanotechnology, Polyphosphates, Quorum Sensing, Recombinant Fusion Proteins, S-Adenosylhomocysteine, Serum Albumin, Bovine
Abstract

We demonstrate that "nanofactory"-loaded biopolymer capsules placed in the midst of a bacterial population can direct bacterial communication. Quorum sensing (QS) is a process by which bacteria communicate through small-molecules, such as autoinducer-2 (AI-2), leading to collective behaviors such as virulence and biofilm formation. In our approach, a "nanofactory" construct is created, which comprises an antibody complexed with a fusion protein that produces AI-2. These nanofactories are entrapped within capsules formed by electrostatic complexation of cationic (chitosan) and anionic (sodium alginate) biopolymers. The chitosan capsule shell is crosslinked by tripolyphosphate (TPP) to confer structural integrity. The capsule shell is impermeable to the encapsulated nanofactories, but freely permeable to small molecules. In turn, the capsules are able to take in substrates from the external medium via diffusion, and convert these via the nanofactories into AI-2, which then diffuses out. The exported AI-2 is shown to stimulate QS responses in vicinal Escherichia coli. Directing bacterial population behavior has potential applications in next-generation antimicrobial therapy and pathogen detection. We also envision such capsules to be akin to artificial "cells" that can participate in native biological signaling and communicate in real-time with the human microbiome. Through such interaction capabilities, these "cells" may sense the health of the microbiome, and direct its function in a desired, host-friendly manner.

DOI10.1002/bit.24711
Alternate JournalBiotechnol. Bioeng.
PubMed ID22903626